Stay updated with breaking news from Johan Dighed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STOCKHOLM, Sweden, June 23, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Promimic today presented preclinical results tshowing that the company's HAnano
STOCKHOLM, SWEDEN, May 17 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has completed the acquisition of the privately-held US-based biotechnology
STOCKHOLM, Sweden, May 2, 2022. Karolinska Development AB announces that its portfolio company Biosergen is preparing a Phase 2 clinical trial of the company’s lead compound BSG005, targeting... | May 2, 2022
Investegate announcements from Karolinska Development AB (pub, Karolinska Development’s portfolio company Biosergen prepares Phase 2 study in mucormycosis infected patients
STOCKHOLM, Sweden, May 2, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Biosergen is preparing a Phase 2 clinical trial of the company's lead compound BSG005